TIL

Instil Bio, Inc.

There isn't enough reported data to score TIL yet.

TIL Fundamentals

MetricStatus
Weak
Under pressure
Unavailable
Unavailable

TIL's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.

TIL PE Valuation

TIL has no meaningful PE right now: it lost money over the past year.

TIL Forward outlook

There aren't enough analyst estimates for TIL to show an outlook.

TIL Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $6.24 on Nov 12.

There is not enough scenario data to assess TIL's risk to reward.

TIL Earnings Per Share

Q3 2023: $-30.20Q4 2023: $-24.00Q1 2024: $-18.94Q2 2024: $-18.43Q3 2024: $-11.57Q4 2024: $-11.39Q1 2025: $-11.97Q2 2025: $-12.92Q3 2025: $-11.39Q4 2025: $-10.70Q1 2026: $-7.00Q2 2026: $-4.39
Q3 2023: $-30.20Q4 2023: $-24.00Q1 2024: $-18.94Q2 2024: $-18.43Q3 2024: $-11.57Q4 2024: $-11.39Q1 2025: $-11.97Q2 2025: $-12.92Q3 2025: $-11.39Q4 2025: $-10.70Q1 2026: $-7.00Q2 2026: $-4.39
QuarterTTM EPSYoY
Q2 2026-$4.39+$8.53
Q1 2026-$7.00+$4.97
Q4 2025-$10.70+$0.69
Q3 2025-$11.39+$0.18
Q2 2025-$12.92+$5.51
Q1 2025-$11.97+$6.97
Q4 2024-$11.39+$12.61
Q3 2024-$11.57+$18.63

TIL is still losing money, but far less than before: $4.39 per share over the past year, against $34.80 at its worst in early 2023.

TIL Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

TIL's revenue has slid since its 2020 peak: $0 last quarter.

TIL Free Cash Flow

Q3 2023: −$20MQ4 2023: −$13MQ1 2024: −$14MQ2 2024: −$11MQ3 2024: −$20MQ4 2024: −$11MQ1 2025: −$4MQ2 2025: −$15MQ3 2025: −$11MQ4 2025: −$7MQ1 2026: −$1MQ2 2026: −$5M
Q3 2023: −$20MQ4 2023: −$13MQ1 2024: −$14MQ2 2024: −$11MQ3 2024: −$20MQ4 2024: −$11MQ1 2025: −$4MQ2 2025: −$15MQ3 2025: −$11MQ4 2025: −$7MQ1 2026: −$1MQ2 2026: −$5M
QuarterFree cash flowYoY
Q2 2026-$4.6M+$10.1M
Q1 2026-$1.3M+$2.9M
Q4 2025-$7.1M+$3.5M
Q3 2025-$10.6M+$9.6M
Q2 2025-$14.8M-$4.2M
Q1 2025-$4.2M+$10.2M
Q4 2024-$10.6M+$2.9M
Q3 2024-$20.1M-$549K

TIL has burned cash in almost every quarter: −$24M over the past year, against −$50M the year before.

TIL Total Shares

Q3 2023: 7MQ4 2023: 7MQ1 2024: 7MQ2 2024: 7MQ3 2024: 7MQ4 2024: 7MQ1 2025: 7MQ2 2025: 7MQ3 2025: 7MQ4 2025: 7MQ1 2026: 7MQ2 2026: 7M
Q3 2023: 7MQ4 2023: 7MQ1 2024: 7MQ2 2024: 7MQ3 2024: 7MQ4 2024: 7MQ1 2025: 7MQ2 2025: 7MQ3 2025: 7MQ4 2025: 7MQ1 2026: 7MQ2 2026: 7M
PeriodChange %Net change
Quarterly0%--
1 year+2.8%+185K shares
3 years+4.3%+278K shares
5 years+5.4%+345K shares

TIL has 7M diluted shares, up 2.8% from a year ago.

TIL Net Leverage

TIL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

TIL Weekly Momentum

MetricValueStatus
RSI36.5Neutral
Stochastic45.6Neutral

TIL's weekly RSI is 36 (neutral) and its Stochastic is 46 (neutral).

TIL PE vs Healthcare Sector

TIL has no meaningful PE right now: it lost money over the past year.

TIL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$6.595.3% below
20 week MA$7.0912% below
50 week MA$7.9522% below
100 week MA$14.657% below
200 week MA$14.958% below

TIL is in a downtrend: it's below all five of its weekly moving averages, and 58% below its 200-week average.

TIL Yearly ROI

YearStart priceEnd priceROI
2021$528.8$322.6-39%
2022$322.6$10.0-97%
2023$10.0$7.62-24%
2024$7.62$20.1+163%
2025$20.1$11.3-44%
2026 YTD$11.3$6.24-45%

TIL's yearly returns have swung widely, from +163% in 2024 to −97% in 2022. It's down 45% so far in 2026.

Give your agent the market.

Get API key